CRH (CRH) Stock Forecast & Price Target

$92.50

-0.74 (-0.79%)

(As of 09/27/2024 ET)

CRH - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 10 Analyst Ratings

Sell
0

Hold
2

Buy
8

Based on 10 Wall Street analysts who have issued ratings for CRH in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 2 have given a hold rating, and 8 have given a buy rating for CRH.

Consensus Price Target

$95.70
3.46% Upside

According to the 10 analysts' twelve-month price targets for CRH, the average price target is $95.70. The highest price target for CRH is $110.00, while the lowest price target for CRH is $58.00. The average price target represents a forecasted upside of 3.46% from the current price of $92.50.

CRH Analyst Ratings Over Time

Type	Current Forecast 9/29/23 to 9/28/24	1 Month Ago 8/30/23 to 8/29/24	3 Months Ago 7/1/23 to 6/30/24	1 Year Ago 9/29/22 to 9/29/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	8 Buy rating(s)	7 Buy rating(s)	3 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$95.70	$95.70	$93.11	$6.50
Forecasted Upside	3.46% Upside	8.36% Upside	24.18% Upside	-88.12% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

FDA’s hidden signal greenlights biotech winners — 97% of the time (Ad)

The FDA has started to quietly send out a signal … That has given investors a 97% chance of making money. Perhaps as soon as 9:30 a.m. tomorrow.

Click here to find out how you can get in before the FDA’s potential signal.

CRH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CRH Stock vs. The Competition

Type	CRH	Construction Companies	S&P 500
Consensus Rating Score	2.80	2.57	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	3.46% Upside	26.74% Upside	6.14% Upside
News Sentiment Rating	Positive News See Recent CRH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/9/2024	DA Davidson 3 of 5 stars		Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	+32.24%
8/9/2024	Truist Financial 2 of 5 stars		Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	+34.90%
7/11/2024	Citigroup 3 of 5 stars		Lower Target	Buy ➝ Buy	$109.00 ➝ $99.00	+25.21%
7/9/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$87.00 ➝ $88.00	+18.53%
6/18/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Grooms Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$95.00	+20.68%
5/14/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$110.00	+33.95%
4/15/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold	$80.00 ➝ $82.00	-0.53%
3/22/2024	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$105.00	+22.42%
3/4/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$89.70 ➝ $100.00	+19.62%
11/6/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$58.00	+1.97%
6/15/2023	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$6.50	-87.97%
12/8/2022	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	€50.00 ➝ €48.00
11/23/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	€50.00 ➝ €48.00

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:03 PM ET.

Should I Buy CRH Stock? CRH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 24, 2024. Please send any questions or comments about these CRH pros and cons to contact@marketbeat.com.

CRH
Bull Case

Here are some ways that investors could benefit from investing in CRH plc:

CRH plc has consistently met or exceeded earnings per share estimates, indicating strong financial performance.
Analysts have set a target price of $95.70 for CRH plc, suggesting potential for stock price appreciation.
CRH plc offers a dividend yield of 1.7%, providing investors with a steady income stream.
Recent analyst reports have given CRH plc a "Moderate Buy" rating, indicating positive sentiment from experts.
CRH plc operates in multiple segments, diversifying its revenue streams and potentially reducing risk for investors.

CRH
Bear Case

Investors should be bearish about investing in CRH plc for these reasons:

CRH plc reported revenue below consensus estimates, which may raise concerns about future growth prospects.
Despite positive ratings, CRH plc has received some downgrades from analysts, indicating potential risks in the market.
The stock price of CRH plc has fluctuated, with a 1-year high of $91.02 and a 1-year low of $51.59, showing volatility.
CRH plc recently cut its dividend, which could impact investor confidence in the company's financial stability.
Market conditions and economic factors may influence the construction industry, affecting CRH plc's performance and stock price.

CRH Forecast - Frequently Asked Questions

: According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for CRH is $95.70, with a high forecast of $110.00 and a low forecast of $58.00.
: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CRH shares.
: According to analysts, CRH's stock has a predicted upside of 3.46% based on their 12-month stock forecasts.
: Over the previous 90 days, CRH's stock had 1 upgrade by analysts.
: CRH has been rated by research analysts at Citigroup, DA Davidson, Morgan Stanley, and Truist Financial in the past 90 days.
: Analysts like CRH more than other "construction" companies. The consensus rating score for CRH is 2.80 while the average consensus rating score for "construction" companies is 2.57. Learn more on how CRH compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

FDA’s hidden signal greenlights biotech winners — 97% of the time (Ad)

The FDA has started to quietly send out a signal … That has given investors a 97% chance of making money. Perhaps as soon as 9:30 a.m. tomorrow.

Click here to find out how you can get in before the FDA’s potential signal.

This page (NYSE:CRH) was last updated on 9/28/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

CRH (CRH) Stock Forecast & Price Target